 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Course Foundations: Introduction to Performance Procedures

Validation of Dissolution and Other Performance Procedures

Learning Objective

Core Concepts and Workflow Application

Slide 2: Concept Simplified (≈60 sec)

Slide 3: Case Study with Characters (≈90 sec)

Slide 4: Practical Application (≈60 sec)

Summary and Inspection Readiness

10 Key Concepts from the Module

10-Point Audit / Inspection Checklist

Copy of 10-Point Audit / Inspection Checklist

Quiz

Quiz 1: Fundamentals of Dissolution Validation

Quiz 2: Q2(R2) Tables and Ranges

Quiz 3: Immediate vs. Modified Release Validation

Quiz 4: Troubleshooting and Common Errors

Quiz 5: Audit Readiness and Compliance

Survey/Feedback

Course Effectiveness Evaluation

Practical Application and Competency Feedback

Welcome to the definitive guide on "Validating Dissolution and Performance Procedures Under ICH Q2(R2)". In the highly regulated pharmaceutical industry, ensuring the consistent quality and performance of drug products is paramount.

Welcome to the definitive guide on "Validating Dissolution and Performance Procedures Under ICH Q2(R2)". In the highly regulated pharmaceutical industry, ensuring the consistent quality and performance of drug products is paramount. Dissolution testing serves as a critical surrogate for in vivo bioavailability, directly impacting patient safety and product efficacy. However, validating these performance procedures requires a nuanced understanding of the latest regulatory expectations, specifically the ICH Q2(R2) guidelines. This comprehensive course is designed to bridge the gap between theoretical guidelines and practical laboratory application. Throughout this program, you will explore the foundational principles of analytical procedure validation as it applies to dissolution, differentiating it from standard assays. We will dive deep into ICH Q2(R2) Tables 1 and 2, unpacking the specific validation characteristics, reportable ranges, and lower limit expectations for both immediate-release (IR) and modified-release (MR) products. Beyond the theory, this course offers realistic case studies, troubleshooting techniques for common analytical errors (such as excipient interference), and actionable strategies for concurrent studies like filter compatibility and solution stability. Finally, you will gain access to a robust 10-point audit and inspection checklist to ensure your internal protocols not only meet regulatory standards but are fully inspection-ready. Whether you are a quality control analyst, a regulatory affairs professional, or a laboratory manager, this course will equip you with the expertise to confidently validate dissolution procedures and safeguard your product's quality lifecycle.

Validating Dissolution and Performance Procedures Under ICH Q2(R2)

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>Dissolution testing serves as a critical surrogate for in vivo bioavailability, directly impacting patient safety and the assurance of continuous product quality. With the implementation of the ICH Q2(R2) guideline, regulatory expectations for validating analytical performance procedures have evolved, necessitating a refined approach to method validation. This course provides a comprehensive examination of these updated requirements, distinguishing performance procedures from standard assays. It establishes the foundational principles necessary to ensure consistent drug product evaluation, emphasizing how robust validation protocols safeguard both regulatory compliance and product integrity.</p>

<p>Throughout this program, participants will systematically navigate the validation lifecycle of dissolution procedures. The curriculum bridges theoretical guidelines with practical application, exploring specific validation characteristics and reportable ranges outlined in ICH Q2(R2) Tables 1 and 2. Learners will analyze complex scenarios, including immediate versus modified-release profiles, and evaluate borderline situations such as early timepoint readings approaching the quantitation limit. By progressing through core concepts, realistic case studies, and the practical troubleshooting of common analytical errors—such as excipient interference—professionals will acquire the expertise required to design compliant validation protocols. Ultimately, the course culminates in actionable strategies for audit and inspection readiness, ensuring that internal protocols, filter compatibility studies, and solution stability data can withstand rigorous regulatory scrutiny.</p>
        </div>
    </div>
</div>
